{"transactions":[{"id":1318387,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2025-01-03T02:21:43.000Z","date":"2024-12-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan."}],"balance_after":20000,"derivative":{"exercise_price":0.5995,"expiration_date":"2034-12-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-000136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315225000136/ownership.xml","form_type":"4"}},{"id":1622125,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-24T00:18:21.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":16666,"derivative":{"exercise_price":0.9,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001493152-24-007743","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224007743/ownership.xml","form_type":"4"}},{"id":1723556,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the option vested on September 13, 2022 (the \"2022 Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the 2022 Date of Grant, a further 25% to vest on the six-month anniversary of the 2022 Date of Grant, and the final 25% to vest on the nine-month anniversary of the 2022 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723555,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option vested on December 29, 2021 (the \" 2021 Date of Grant\"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":20.2,"expiration_date":"2031-12-29","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723554,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"20% of the option vested on December 22, 2020 (the \"2020 Date of Grant\"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":16.8,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723553,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":14.4,"exercise_date":"2020-10-01","expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":1723552,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-12-05T01:45:02.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":3334,"derivative":{"exercise_price":1.24,"expiration_date":"2023-11-15","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001493152-23-043635","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223043635/ownership.xml","form_type":"4"}},{"id":2232831,"issuer":{"id":126213,"kind":"organization","name":"Globis Acquisition Corp.","symbol":"GLAQU"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2022-06-14T06:30:13.000Z","date":"2022-06-09","kind":"other","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As described in the Form 8-K, in connection with the closing of the Business Combination, the private placement warrants were exchanged for warrants to acquire Ordinary Shares at an exercise price of $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrants became exercisable upon the completion of the Business Combination."}],"balance_after":0,"derivative":{"exercise_price":11.5,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-22-016643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823383/000149315222016643/ownership.xml","form_type":"4"}},{"id":2232830,"issuer":{"id":126213,"kind":"organization","name":"Globis Acquisition Corp.","symbol":"GLAQU"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T06:30:13.000Z","date":"2022-06-09","kind":"other","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 9, 2022, the issuer consummated its initial business combination (the \"Business Combination\") with Forafric Global PLC. (\"New Forafric\"), a Gibraltar public company limited by shares. As described in Globis Acquisition Corp.'s Current Report on Form 8-K (File No. 333-262126) filed on June 9, 2022 (the \"Form 8-K\"), in connection with the closing of the Business Combination, each share of Common Stock was exchanged for one ordinary share, nominal value $0.001 per share, of New Forafric (each, an \"Ordinary Share\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-22-016643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823383/000149315222016643/ownership.xml","form_type":"4"}},{"id":2454518,"issuer":{"id":126213,"kind":"organization","name":"Globis Acquisition Corp.","symbol":"GLAQU"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2022-01-03T11:03:52.000Z","date":"2021-12-29","kind":"gift","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants will become exercisable on the completion of an initial business combination."}],"balance_after":20000,"derivative":{"exercise_price":11.5,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-22-000055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823383/000149315222000055/ownership.xml","form_type":"4"}},{"id":2454517,"issuer":{"id":126213,"kind":"organization","name":"Globis Acquisition Corp.","symbol":"GLAQU"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T11:03:52.000Z","date":"2021-02-24","kind":"gift","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001493152-22-000055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823383/000149315222000055/ownership.xml","form_type":"4"}},{"id":2456039,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-12-30T22:01:26.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vested on December 29, 2021 (the \"Date of Grant\"), with an additional 25% to vest on the three-month anniversary of the Date of Grant, a\nfurther 25% to vest on the six-month anniversary of the Date of Grant, and the final 25% to vest on the nine-month anniversary of the Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan."}],"balance_after":57500,"derivative":{"exercise_price":1.01,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001493152-21-032873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315221032873/ownership.xml","form_type":"4"}},{"id":2931022,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-12-29T02:30:09.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20% of the option vested on December 22, 2020 (the \"Date of Grant\"), with an additional 20% to vest on the three month anniversary of the Date of Grant, a further 20% to vest on the six month anniversary of the Date of Grant, a further 20% to vest on the nine month anniversary of the Date of Grant, and the final 20% to vest on the year anniversary of the Date of Grant."}],"balance_after":85000,"derivative":{"exercise_price":0.84,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001493152-20-024403","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220024403/ownership.xml","form_type":"4"}},{"id":2992423,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T22:52:38.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":2.83,"exercise_date":"2019-12-04","expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001493152-20-020491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/ownership.xml","form_type":"4"}},{"id":2992422,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T22:52:38.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":4.75,"exercise_date":"2018-12-31","expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001493152-20-020491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/ownership.xml","form_type":"4"}},{"id":2992421,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T22:52:38.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":4.75,"exercise_date":"2018-08-14","expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001493152-20-020491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/ownership.xml","form_type":"4"}},{"id":2992420,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T22:52:38.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":5.35,"exercise_date":"2017-07-18","expiration_date":"2026-07-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-020491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/ownership.xml","form_type":"4"}},{"id":2992419,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-11-04T22:52:38.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations."}],"balance_after":0,"derivative":{"exercise_price":2.57,"exercise_date":"2016-04-27","expiration_date":"2025-04-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-20-020491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/ownership.xml","form_type":"4"}},{"id":3012772,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-10-05T23:46:31.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested on October 1, 2020."}],"balance_after":35000,"derivative":{"exercise_price":0.72,"expiration_date":"2030-10-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-20-018957","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220018957/ownership.xml","form_type":"4"}},{"id":3044455,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2020-08-28T19:02:35.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested on July 13, 2020."}],"balance_after":27500,"derivative":{"exercise_price":1.6,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001493152-20-016907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315220016907/ownership.xml","form_type":"4"}},{"id":3349550,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-12-06T20:50:57.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested on December 4, 2019."}],"balance_after":27500,"derivative":{"exercise_price":2.83,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001213900-19-025511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000121390019025511/ownership.xml","form_type":"4"}},{"id":3841457,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-16T20:33:48.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting is subject to the reporting person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Vesting is subject to the reporting person's continued service to the Issuer."}],"balance_after":27500,"derivative":{"exercise_price":4.75,"exercise_date":"2018-12-31","expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001615774-18-008226","document":"s112126_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000161577418008226/s112126_form4.xml","form_type":"4"}},{"id":3841456,"issuer":{"id":8385,"kind":"organization","name":"ENvue Medical, Inc."},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-16T20:33:48.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21250,"derivative":{"exercise_price":4.75,"exercise_date":"2018-08-14","expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001615774-18-008226","document":"s112126_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326706/000161577418008226/s112126_form4.xml","form_type":"4"}},{"id":4184073,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-18T18:00:52.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a reduction of options to purchase 250,000 shares of common stock subject to the stock option, the excess portion of shares of common stock subject to the stock options granted to the reporting\nperson on May 12, 2017, in connection with the reporting person's appointment to the board of directors of the Issuer, which excess portion has been determined to have been in excess of annual plan limits\nset forth in the Issuer's 2016 Consolidated Stock Incentive Plan, and thus rescinded and canceled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 shares of common stock subject to the stock option became exercisable immediately, and 125,000 shares of common stock subject to the stock option will become exercisable on each of\nMay 12, 2018 and May 12, 2019."}],"balance_after":500000,"derivative":{"exercise_price":0.65,"expiration_date":"2022-05-11","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001387131-17-005086","document":"ferguson-form4a_051217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000138713117005086/ferguson-form4a_051217.xml","form_type":"4/A","original_submission_date":"2017-05-16"}},{"id":4318531,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":84592,"kind":"person","name":"Ferguson Michael","position":1,"cik":"0001607534","reported_name":"Ferguson Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-16T17:07:48.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares of common stock subject to the stock option became exercisable immediately, and 1/3 of the shares of common stock subject to the stock option will become exercisable on each of May 12, 2018 and May 12, 2019."}],"balance_after":750000,"derivative":{"exercise_price":0.65,"expiration_date":"2022-05-11","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001387131-17-002848","document":"ferguson-form4_051217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000138713117002848/ferguson-form4_051217.xml","form_type":"4"}}]}